Abstract
Phenoxybenzamine, but not phentolamine or propranolol, blocked central noradrenaline receptors in flexor reflex experiments on the rat spinal cord using the selective noradrenaline receptor stimulating agent clonidine. None of these three drugs blocked dopamine receptors in experiments on turning of unilaterally striatectomized rats induced by the dopamine receptor stimulating agent apomorphine. The α-methyltyrosine-induced disappearance of noradrenaline in the central nervous system of rats and mice was accelerated by phenoxybenzamine at doses related to the functional changes, whereas the other drugs were inefficient. The disappearance of dopamine was decelerated by phenoxybenzamine, but not by phentolamine or propranolol.
The effects of the adrenergic receptor blocking agents on motor activity were studied in a model in which clonidine potentiated the activation induced by apomorphine in reserpine-treated mice. Phentolamine (20 mg/kg) and propranolol (10 mg/kg) reduced the stimulation seen both after apomorphine alone and in combination with clonidine, indicating nonspecific sedative effects. Phentolamine (10 mg/kg) blocked the peripheral effects of clonidine but did not markedly diminish the activation induced by the receptor stimulants. Phenoxybenzamine (20 mg/kg) blocked the clonidine-induced potentiation without interfering with the apomorphine-induced stimulation and can thus be used as a blocking agent of central and peripheral noradrenaline receptors in behavioural experiments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9 (I), 513–523 (1970)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents. Europ. J. Pharmacol. 2, 59–64 (1967a)
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K.: Functional role of the nigroneostriatal dopamine neurons. Acta pharmacol. (Kbh.) 24, 263–274 (1966)
Andén, N.-E., Lundberg, A., Rosengren, E., Vyklický, L.: The effect of dopa on spinal reflexes from the FRA (flexor reflex afferents). Experientia (Basel) 19, 654 (1963)
Andén, N.-E., Roos, B.-E., Werdinius, B.: Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci. 3, 149–158 (1964)
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967b)
Andén, N.-E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)
Bertler, å., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand. 44, 273–292 (1958)
Boissier, J. R., Simon, P., Giudicelli, J. F.: Effets centraux de quelques substances adréno-et/ou sympatholytiques. II. — Action sur la motilité spontanée et potentialisation du pentobarbital. Arch. int. Pharmacodyn. 169, 312–319 (1967)
Brodie, B. B., Aronow, L., Axelrod, J.: The fate of dibenzyline in the body and the role of fat in its duration of action. J. Pharmacol. exp. Ther. 111, 21–29 (1954)
Carlsson, A., Lindqvist, M.: In-vivo decarboxylation of α-methyl dopa and α-methyl metatyrosine. Acta physiol. scand. 54, 87–94 (1962)
Carlsson, A., Lindqvist, M.: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta pharmacol. (Kbh.) 20, 140–144 (1963)
Carlsson, A., Waldeck, B.: A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta physiol. scand. 44, 293–298 (1958)
Dairman, W., Gordon, R., Spector, S., Sjoerdsma, A., Udenfriend, S.: Increased synthesis of catecholamine in the intact rat following administration of α-adrenergic blocking agents. Molec. Pharmacol. 4, 457–464 (1968)
Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl.) 10, 316–323 (1967)
Galambos, E., Pfeifer, A. K., György, L., Molnár, J.: Study on the excitation induced by amphetamine, cocaine and α-methyltryptamine. Psychopharmacologia (Berl.) 11, 122–129 (1967)
HÄggendal, J.: An improved method for fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta physiol. scand. 59, 242–254 (1963)
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6-Dichlor-phenylamino)-2-imidazolin-hydrochlorids, einer neuen, antihypertensiven Substanz. Arzneimittel-Forsch. 16, 1038–1058 (1966)
Kleinrok, Z., żebrowska-łupina, I.: Central action of phentolamine administered intraventricularly in the rat. Psychopharmacologia (Berl.) 20, 348–354 (1971)
Laverty, R., Taylor, K. M.: Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolism. J. Pharm. Pharmacol. 20, 605–609 (1968)
Maj, J., Grabowska, M., Gajda, L.: Effect of apomorphine on motility in rats. Europ. J. Pharmacol. 17, 208–214 (1972)
Maj, J., Sowińska, H., Baran, L., Kapturkiewicz, Z.: The effect of clonidine on locomotor activity in mice. Life Sci. 11 (I), 483–491 (1972)
Margules, D. L.: Alpha and beta adrenergic receptors in amygdala: reciprocal inhibitors and facilitators of punished operant behavior. Europ. J. Pharmacol. 16, 21–26 (1971)
Masuoka, D., Appelgren, L.-E., Hansson, E.: Autoradiographic distribution studies of adrenergic blocking agents. I. 14C-Phenoxybenzamine (bensylyt NFN), an α-receptor type blocking agent. Acta pharmacol. (Kbh.) 25, 113–122 (1967)
Masuoka, D., Hansson, E.: Autoradiographic distribution studies of adrenergic blocking agents. II. 14C-Propranolol, a Β-receptor-type blocker. Acta pharmacol. (Kbh.) 25, 447–455 (1967)
Meek, J. L., Neff, N. H.: The rate of formation of 3-methoxy-4-hydroxyphenyl-ethyleneglycol sulfate in brain as an estimate of the rate of formation of norepinephrine. J. Pharmacol. exp. Ther. 184, 570–575 (1973)
Modigh, K.: Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacologia (Berl.) 23, 48–54 (1972)
Nickerson, M., Hollenberg, N. K.: Blockade of α-adrenergic receptors. In: Physiological Pharmacology, W. S. Root and F. G. Hofmann, Eds., vol. IV, pp. 243–305. New York-London: Academic Press 1967
O'Keeffe, R., Sharman, D. F., Vogt, M.: Effect of drugs used in psychoses on cerebral dopamine metabolism. Brit. J. Pharmacol. 38, 287–304 (1970)
Roos, B.-E., Steg, G.: The effect of l-3,4-dihydroxyphenylalanine and dl-5-hydroxytryptophan on rigidity and tremor induced by reserpine, chlorpromazine and phenoxybenzamine. Life Sci. 3, 351–360 (1964)
Svensson, T. H.: On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse. Naunyn-Schmiedebergs Arch. Pharmak. 271, 111–120 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andén, N.E., Strömbom, U. Adrenergic receptor blocking agents: Effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia 38, 91–103 (1974). https://doi.org/10.1007/BF00426104
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00426104